Cargando…
Treatment of the hypertensive patient in 2030
Sarah Bingham, a 45 year old carer for her grandmother who suffered a stroke 4 months ago, feels a buzz on her wrist. It’s time for them both to take their medications. Sarah makes dinner and leaves for her evening run. Her smartwatch detects her exit and turns off her TV as advertisements for incen...
Autor principal: | Bhudia, Roshni P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7597427/ https://www.ncbi.nlm.nih.gov/pubmed/33127958 http://dx.doi.org/10.1038/s41371-020-00437-9 |
Ejemplares similares
-
Hypertension management in 2030: a kaleidoscopic view
por: Kulkarni, Spoorthy
Publicado: (2020) -
The World Health Organization Prequalification Program and Clinical Pharmacology in 2030
por: Blaschke, Terrence F., et al.
Publicado: (2019) -
A threefold approach to rescue the 2030 Agenda from failing
por: Pradhan, Prajal
Publicado: (2023) -
Response to "Pharmacovigilance 2030: Invited Commentary for the January 2020 ‘Futures’ Edition"
por: Hauben, Manfred, et al.
Publicado: (2020) -
Universal health coverage and primary health care: the 30 by 2030 campaign
por: De Maeseneer, Jan, et al.
Publicado: (2020)